How RAS inhibitors affect the aggressiveness of prostate cancer

Leipzig – The prostate cancers of patients treated with renin-angiotensin system (RAS) inhibitors are less aggressive than tumors that are RAS inhibitor-naive. This is suggested by new data presented by Nastasiia Artamonova, Medical University of